FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1133344 · Received August 22, 2008

Report

Report Number
2024168-2008-00703
Event Type
Injury
Date Received
August 22, 2008
Date of Event
July 25, 2008
Report Date
July 25, 2008
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS AND CONCLUSIONS SUMMATION: DISSECTION IS LISTED IN THE IFU AS A KNOWN ADVERSE EVENT ASSOCIATED WITH CORONARY STENTING. THIS KNOWN PT EFFECT IS NOT NECESSARILY AN INDICATION OF PROD QUALITY ISSUE. DISSECTION CAN BE INFLUENCED BY SEVERAL FACTORS INCLUDING BUT NOT LIMITED TO, LESION CHARACTERISTICS, PROCEDURAL TECHNIQUE, AND DEVICE SIZE SELECTION. THE IFU ALSO CAUTIONS THAT "IMPLANTING A STENT MAY LEAD TO DISSECTION OF THE VESSEL DISTAL AND/OR PROXIMAL TO THE STENT AND MAY CAUSE ACUTE CLOSURE OF THE VESSEL REQUIRING ADD'L INTERVENTION (CABG, FURTHER DILATATION, PLACEMENT OF ADD'L STENT, OR OTHER)". A CONCLUSIVE ROOT CAUSE FOR THE REPORTED EVENT AND THE RELATIONSHIP TO THE DEVICE IF ANY, CANNOT BE DETERMINED.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY/MEDICAL INTERVENTION. REPORTING RATIONALE: DISSECTION REQUIRING MEDICAL INTERVENTION TO PREVENT PERMANENT DAMAGE. DEVICE ISSUE: NONE. IT WAS REPORTED THAT DURING THE USE OF THE XIENCE V STENT DELIVERY SYSTEM (SDS) A DISSECTION OCCURRED. ANOTHER XIENCE V SDS WAS USED TO TREAT THE DISSECTION. NO ADD'L EVENT OR PT INFO IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA 8010861

Patients

Seq Age Sex Outcome Treatment
1 73 YR Required Intervention STENT: XIENCE V 2.5 X 18 MM| DIL CATH: VOYAGER| GUIDE CATH: EBU| GUIDE WIRE: BMW